Living with Fabry disease? See if you qualify

Thank you for your interest in discovering more about a new clinical study that is currently enrolling men and women living with Fabry disease.

See if you qualify


The STAAR study has been designed to investigate the potential of an investigational gene therapy called ST-920 to treat men and women living with Fabry disease.

You may qualify if:

  • You are aged 18 years or older
  • You have been diagnosed as having Fabry disease

People who qualify will receive:

  • Study-related medical care
  • Reimbursement for travel
  • All people who pass screening assessments and enter into the study will receive the study drug ST-920